Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

50 Marks
Corp.
First Filed:Jul 13, 2010Latest Filed:Dec 24, 2025Address:88 Sidney Street, Cambridge, MA 02139, US

Portfolio Overview

Previous
7

Top Classes

Class 5
Pharmaceuticals
36(72%)
Class 42
Software, IT Services & Scientific Research
10(20%)
Class 44
Medical, beauty and agricultural services
8(16%)

TTAB Proceedings

Proceedings
0
As Plaintiff
0(0%)
As Defendant
0(0%)
Extensions of Time
1

Top Firms

Loading...

Trademark Activity Timeline(2010 – 2026)

Trademark Portfolio

57 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
99564933
99564933
Trademark
Design
PENDING
Owner:
Serial:99564933
Filed:Dec 24, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of anemia in patients with inherited blood disorders
AQVESME
AQVESME
Trademark
Combined
REGISTERED
Owner:
Serial:99564383
Filed:Dec 23, 2025
Classes:5
Registration:8445189
Registered:Sep 15, 2026
Description: Pharmaceutical preparations for the treatment of anemia in patients with inherited blood disorders
AQVESME
AQVESME
Trademark
Word
REGISTERED
Owner:
Serial:99351679
Filed:Aug 22, 2025
Classes:5
Registration:8444566
Registered:Sep 15, 2026
Description: Pharmaceutical preparations for the treatment of blood disorders, hemolytic anemia and diseases effecting red blood cells
AQVYGO
AQVYGO
Trademark
Word
PENDING
Owner:
Serial:99351817
Filed:Aug 22, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of blood disorders, hemolytic anemia and diseases effecting red blood cells
98891935
98891935
Trademark
Design
PENDING
Owner:
Serial:98891935
Filed:Dec 9, 2024
Classes:5
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
PYRUKYND
PYRUKYND
Trademark
Combined
PENDING
Owner:
Serial:98892062
Filed:Dec 9, 2024
Classes:5
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
RETHINK THALASSEMIA
RETHINK THALASSEMIA
Service Mark
Word
PENDING
Owner:
Serial:98514768
Filed:Apr 23, 2024
Classes:41, 42, 44, +1
Description: Education services, namely, providing mentoring, tutoring, classes, seminars and workshops in the field of diagnosis, management and treatment of thalassemia; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; Providing health information; Providing medical information via a website; "THALASSEMIA"; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
ALLY VOICES RISING
ALLY VOICES RISING
Service Mark
Stylized
PENDING
Owner:
Serial:98505739
Filed:Apr 17, 2024
Classes:35, 41, 44
Description: Education services, namely, providing mentoring, tutoring, classes, seminars and workshops in the field of diagnosis, management and treatment of hematological disorders; Promoting public awareness of hematological disorders and their treatment and management; Providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; Providing health information; Providing medical information via a website
MYPKD
MYPKD
Trademark
Word
REGISTERED
Owner:
Serial:98474811
Filed:Mar 29, 2024
Classes:9
Registration:7765711
Registered:Apr 22, 2025
Description: Downloadable software in the nature of a mobile application to allow patients and healthcare professionals to access, collect and share information in the management of pyruvate kinase deficiency; downloadable software in the nature of a mobile application to provide information related to the management of pyruvate kinase deficiency
RED CELL REVOLUTION
RED CELL REVOLUTION
Trademark
Word
PENDING
Owner:
Serial:97880268
Filed:Apr 10, 2023
Classes:9, 35, 41, +2
Description: Education services, namely, providing online, non-downloadable electronic publications in the nature of posters, manuscripts, abstracts and white papers in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; oral presentations, workshops, symposiums and round table discussions, both online and in person in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; providing webcasts and podcasts in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; Downloadable electronic publications in the nature of posters, manuscripts, abstracts and white papers in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; Promoting public awareness of hemolytic anemias and of the treatment and management of hemolytic anemias; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing health information; Providing health information in the nature of social media and web site postings in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; "RED CELL"
RED CELL REVOLUTION
RED CELL REVOLUTION
Trademark
Combined
PENDING
Owner:
Serial:97880273
Filed:Apr 10, 2023
Classes:9, 35, 41, +2
Description: Education services, namely, providing online, non-downloadable electronic publications in the nature of posters, manuscripts, abstracts and white papers in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; oral presentations, workshops, symposiums and round table discussions, both online and in person in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; providing webcasts and podcasts in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; Downloadable electronic publications in the nature of posters, manuscripts, abstracts and white papers in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; Promoting public awareness of hemolytic anemias and of the treatment and management of hemolytic anemias; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing health information; Providing health information in the nature of social media and web site postings in the field of hemolytic anemias and of the treatment and management of hemolytic anemias; "RED CELL"
THALPALS: THE ALPHA BETA REVOLUTION
THALPALS: THE ALPHA BETA REVOLUTION
Trademark
Word
REGISTERED
Owner:
Serial:97363422
Filed:Apr 14, 2022
Classes:9
Registration:7152390
Registered:Aug 29, 2023
Description: Downloadable podcasts in the fields of medicine, science, medical patient care, and medical diagnosis and treatment of diseases
JUST LISTEN: VOICES OF PK DEFICIENCY
JUST LISTEN: VOICES OF PK DEFICIENCY
Trademark
Word
REGISTERED
Owner:
Serial:97130352
Filed:Nov 17, 2021
Classes:9
Registration:6960996
Registered:Jan 24, 2023
Description: Downloadable podcasts in the fields of medicine, science, medical patient care, and medical diagnosis and treatment of diseases
AGIOS PHARMACEUTICALS
AGIOS PHARMACEUTICALS
Trademark
Word
REGISTERED
Owner:
Serial:97108511
Filed:Nov 4, 2021
Classes:5
Registration:6993175
Registered:Feb 28, 2023
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
BUILDING CONNECTIONS, PIONEERING THERAPIES.
BUILDING CONNECTIONS, PIONEERING THERAPIES.
Service Mark
Word
ABANDONED
Owner:
Serial:97108539
Filed:Nov 4, 2021
Classes:42, 44
Description: Providing health care information in connection with patient and family support programs; providing a website for medical professionals and medical patients featuring information on the prevention and treatment of diseases; providing online information in the field of diagnosis and treatment of diseases; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; "THERAPIES"; Providing medical and scientific research information in the field of clinical trials
FUELED BY CONNECTIONS.
FUELED BY CONNECTIONS.
Service Mark
Word
ABANDONED
Owner:
Serial:97108526
Filed:Nov 4, 2021
Classes:42, 44
Description: Providing health care information in connection with patient and family support programs; providing a website for medical professionals and medical patients featuring information on the prevention and treatment of diseases; providing online information in the field of diagnosis and treatment of diseases; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical and scientific research information in the field of clinical trials
AGIOS
AGIOS
Trademark
Combined
ABANDONED
Owner:
Serial:97104793
Filed:Nov 2, 2021
Classes:5, 42
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
ABANDONED
Owner:
Serial:97104784
Filed:Nov 2, 2021
Classes:5, 42
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
ABANDONED
Owner:
Serial:97104777
Filed:Nov 2, 2021
Classes:5, 42
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
REGISTERED
Owner:
Serial:97104763
Filed:Nov 2, 2021
Classes:5, 42
Registration:7027625
Registered:Apr 11, 2023
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
ABANDONED
Owner:
Serial:97104803
Filed:Nov 2, 2021
Classes:5, 42
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
ABANDONED
Owner:
Serial:97104800
Filed:Nov 2, 2021
Classes:5, 42
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Combined
REGISTERED
Owner:
Serial:97104771
Filed:Nov 2, 2021
Classes:5
Registration:7027627
Registered:Apr 11, 2023
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism | Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
AGIOS
AGIOS
Trademark
Word
REGISTERED
Owner:
Serial:97104769
Filed:Nov 2, 2021
Classes:5, 42
Registration:7027626
Registered:Apr 11, 2023
Description: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism; Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
ANEMIA ID
ANEMIA ID
Trademark
Word
REGISTERED
Owner:
Serial:90889223
Filed:Aug 18, 2021
Classes:10
Registration:6816686
Registered:Aug 9, 2022
Description: Specimen collection kits for use in genetic testing comprised primarily of sample collection containers for medical purposes sold empty, instructions, shipping labels and transport packaging | Genetic testing for medical or diagnostic purposes; providing healthcare information
ANEMIA ID
ANEMIA ID
Trademark
Combined
REGISTERED
Owner:
Serial:90889241
Filed:Aug 18, 2021
Classes:10
Registration:6850379
Registered:Sep 20, 2022
Description: Specimen collection kits for use in genetic testing comprised primarily of saliva and blood collection containers for medical purposes sold empty, instructions, shipping labels and transport packaging
90769018
90769018
Trademark
Design
REGISTERED
Owner:
Serial:90769018
Filed:Jun 11, 2021
Classes:5
Registration:6810414
Registered:Aug 2, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
90768846
90768846
Trademark
Design
REGISTERED
Owner:
Serial:90768846
Filed:Jun 11, 2021
Classes:5
Registration:6874039
Registered:Oct 11, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
90768967
90768967
Trademark
Design
REGISTERED
Owner:
Serial:90768967
Filed:Jun 11, 2021
Classes:5
Registration:6874041
Registered:Oct 11, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
90769007
90769007
Trademark
Design
REGISTERED
Owner:
Serial:90769007
Filed:Jun 11, 2021
Classes:5
Registration:6810413
Registered:Aug 2, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
90769030
90769030
Trademark
Design
REGISTERED
Owner:
Serial:90769030
Filed:Jun 11, 2021
Classes:5
Registration:6810415
Registered:Aug 2, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
90769045
90769045
Trademark
Design
ABANDONED
Owner:
Serial:90769045
Filed:Jun 11, 2021
Classes:5
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
PYRUKYND
PYRUKYND
Trademark
Combined
REGISTERED
Owner:
Serial:90768981
Filed:Jun 11, 2021
Classes:5
Registration:6874042
Registered:Oct 11, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
PYRUKYND
PYRUKYND
Trademark
Combined
REGISTERED
Owner:
Serial:90768935
Filed:Jun 11, 2021
Classes:5
Registration:6874040
Registered:Oct 11, 2022
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
PYRUKYND
PYRUKYND
Trademark
Combined
ABANDONED
Owner:
Serial:90768907
Filed:Jun 11, 2021
Classes:5
Description: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
AQVESME
AQVESME
Trademark
Word
ABANDONED
Owner:
Serial:88514687
Filed:Jul 15, 2019
Classes:5
AQVYGO
AQVYGO
Trademark
Word
ABANDONED
Owner:
Serial:88514706
Filed:Jul 15, 2019
Classes:5
ENZIPVIC
ENZIPVIC
Trademark
Word
ABANDONED
Owner:
Serial:88514725
Filed:Jul 15, 2019
Classes:5
PYRUKYND
PYRUKYND
Trademark
Word
REGISTERED
Owner:
Serial:88514664
Filed:Jul 15, 2019
Classes:5
Registration:6302036
Registered:Mar 23, 2021
Description: Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
MYAGIOS
MYAGIOS
Service Mark
Word
REGISTERED
Owner:
Serial:87868181
Filed:Apr 9, 2018
Classes:36, 44
Registration:5760765
Registered:May 28, 2019
Description: Class 36: Patient support services to help eligible patients obtain access to or afford prescription drugs for the treatment of [ cancer and ] rare genetic diseases, namely, financial administration of pharmacy reimbursement programs and services; reimbursement payment processing in the field of insurance claims for pharmaceuticals
Class 44: Charitable services, namely, patient assistance program to provide drugs at reduced cost or free of charge to low-income patients without prescription drug coverage
MYAGIOS
MYAGIOS
Service Mark
Combined
REGISTERED
Owner:
Serial:87868169
Filed:Apr 9, 2018
Classes:36, 44
Registration:5760764
Registered:May 28, 2019
Description: Class 36: Patient support services to help eligible patients obtain access to or afford prescription drugs for the treatment of [ cancer and ] rare genetic diseases, namely, financial administration of pharmacy reimbursement programs and services; reimbursement payment processing in the field of insurance claims for pharmaceuticals
Class 44: Charitable services, namely, patient assistance program to provide drugs at reduced cost or free of charge to low-income patients without prescription drug coverage
87556001
87556001
Trademark
Design
ABANDONED
Owner:
Serial:87556001
Filed:Aug 4, 2017
Classes:5
87556012
87556012
Trademark
Design
ABANDONED
Owner:
Serial:87556012
Filed:Aug 4, 2017
Classes:5
AGIOS
AGIOS
Trademark
Combined
CANCELLED
Owner:
Serial:87410264
Filed:Apr 13, 2017
Classes:5
Registration:5596579
Registered:Oct 30, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
AGIOS PHARMACEUTICALS
AGIOS PHARMACEUTICALS
Trademark
Word
CANCELLED
Owner:
Serial:87410256
Filed:Apr 13, 2017
Classes:5
Registration:5927013
Registered:Dec 3, 2019
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
PROBABILITY OF SUCCESSION SUCCESS
PROBABILITY OF SUCCESSION SUCCESS
Service Mark
Word
ABANDONED
Owner:
Serial:87187204
Filed:Sep 29, 2016
Classes:35
LUMCIMI
LUMCIMI
Trademark
Word
ABANDONED
Owner:
Serial:87182796
Filed:Sep 26, 2016
Classes:5
TIBSOVI
TIBSOVI
Trademark
Word
ABANDONED
Owner:
Serial:87182786
Filed:Sep 26, 2016
Classes:5
CIZIDHA
CIZIDHA
Trademark
Word
ABANDONED
Owner:
Serial:87122181
Filed:Jul 31, 2016
Classes:5
AGIOS
AGIOS
Trademark
Word
CANCELLED
Owner:
Serial:85083902
Filed:Jul 13, 2010
Classes:5
Registration:4625158
Registered:Oct 21, 2014
Description: Pharmaceutical preparations for use in the treatment of cancer
90524684
90524684
Trademark
Design
Previous
REGISTERED
Owner:
Serial:90524684
Filed:Feb 11, 2021
Classes:5
Registration:6668592
Registered:Mar 8, 2022
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
90524701
90524701
Trademark
Design
Previous
REGISTERED
Owner:
Serial:90524701
Filed:Feb 11, 2021
Classes:5
Registration:6668594
Registered:Mar 8, 2022
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
TIBSOVO
TIBSOVO
Trademark
Combined
Previous
REGISTERED
Owner:
Serial:87556017
Filed:Aug 4, 2017
Classes:5
Registration:5587520
Registered:Oct 16, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
TIBSOVO
TIBSOVO
Trademark
Combined
Previous
REGISTERED
Owner:
Serial:87556035
Filed:Aug 4, 2017
Classes:5
Registration:5587521
Registered:Oct 16, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
TIBSOVO IVOSIDENIB TABLETS
TIBSOVO IVOSIDENIB TABLETS
Trademark
Combined
Previous
REGISTERED
Owner:
Serial:87556046
Filed:Aug 4, 2017
Classes:5
Registration:5587522
Registered:Oct 16, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
TIBSOVO IVOSIDENIB TABLETS
TIBSOVO IVOSIDENIB TABLETS
Trademark
Combined
Previous
REGISTERED
Owner:
Serial:87555989
Filed:Aug 4, 2017
Classes:5
Registration:5587519
Registered:Oct 16, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
TIBSOVO
TIBSOVO
Trademark
Word
Previous
REGISTERED
Owner:
Serial:87122179
Filed:Jul 31, 2016
Classes:5
Registration:5444093
Registered:Apr 10, 2018
Description: Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer